Globe 100 | Executive roundtable
What the CEOs see
Four biotech leaders on the recession, venture capital, and how their industry can help lead Massachusetts into a recovery
The hot, burning core of any recovery in Massachusetts could well be occupied by the state's life sciences companies; for evidence, take the preponderance of biotech firms on this year's Globe 100. (Full article: 1210 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $9.95 1 month archives pass
- $24.95 3 months archives pass
- $74.95 1 year archives pass
